Cite
APA Citation
Yusof, M. M., Vital, E., McElvenny, D., Hensor, E., Das, S., Buch, M., Emery, P., & Savic, S. (n.d.). sAT0556 Risk factors for severe infection and rationale for immunoglobulin monitoring during rituximab treatment in autoimmune rheumatic diseases. Annals of the rheumatic diseases, 76, 987. http://access.bl.uk/ark:/81055/vdc_100135154555.0x00005d